The purpose of this study was to determine whether dihydropteroate synthase gene (DHPS) mutations were associated with the failure of sulpha/sulphone drugs used as prophylaxis agents in HIV infected patients. Results suggested that DHPS mutations were significantly associated with failure of anti-Pneumocystis carinii sulphone prophylaxis (P=0.031). An increasing number of mutant P. carinii strains have been isolated from patients no longer having prophylaxis. There was no statistically significant difference in severity or outcome of the pneumonia caused by wild-type or mutant DHPS. Moreover, two of the three patients with mutant P. carinii pneumonia (PCP) were successfully treated with sulpha drugs. We think that P. carinii drug-resistance could be an emerging problem for immunocompromised patients including those with HIV infection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0924-8579(01)00460-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis of Mutations in Dihydropteroate Synthase and Dihydropteroate Reductase Genes Among Non-HIV Patients in China.
Infect Drug Resist
December 2024
Beijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Purpose: pneumonia (PJP) shows a high fatality rate in non-HIV patients. However, there are limited data on drug resistance-related gene mutations in these patients. This study aimed to describe the prevalence of mutations in the dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) genes of in non-HIV patients in China, providing a reference for drug usage.
View Article and Find Full Text PDFTranscriptomic analysis reveals pathways underlying the multi-antibiotic resistance of Klebsiella pneumoniae.
IET Syst Biol
December 2024
Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Klebsiella pneumoniae, an opportunistic pathogen, is pervasively distributed across the world. Its escalating antibiotic resistance poses a serious threat to global public health. The mechanisms behind this resistance remain largely elusive.
View Article and Find Full Text PDFand markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon.
Wellcome Open Res
June 2024
MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.
Background: Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3-59 months from 2016, raising concerns whether drug pressure may lead to a selection of known parasite resistance mutations.
View Article and Find Full Text PDFGenomic characterization of Achromobacter genogroup 20 and identification of a potential species-specific marker.
J Glob Antimicrob Resist
November 2024
Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Laboratorio de Resistencia Bacteriana, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Article Synopsis
- The study aimed to analyze the genome of Achromobacter genogroup 20 and identify resistance determinants related to antibiotic resistance.
- Isolate 413638 was classified as Achromobacter genogroup 20 ST365, demonstrating significant resistance to multiple antibiotics and possessing several resistance-related genetic elements, including a newly identified OXA-type β-lactamase.
- The findings suggest that the resistance markers identified could explain the antibiotic resistance profile of Achromobacter genogroup 20 ST365, with the new OXA variant potentially serving as a useful marker for further species identification.
Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022.
Sci Rep
November 2024
Department of Parasite Disease Control and Prevention, Henan Provincial Key Laboratory of Pathogenic Microbiology, Henan Provincial Medical Key Laboratory of Parasitic Diseases and Vector, Henan Province Center for Disease Control and Prevention, Zhengzhou, People's Republic of China.
Article Synopsis
- Sulfadoxine-pyrimethamine (SP) is crucial for malaria prevention, but parasite resistance poses a challenge, particularly concerning the Pfdhfr and Pfdhps genes associated with SP resistance.
- A study on 508 P. falciparum isolates from West Africa showed high mutation rates in these genes, with common mutations like Pfdhfr N51I and Pfdhps A437G frequently observed across the region.
- Despite high resistance, SP may still reduce low birthweight and maternal anemia, highlighting the need for ongoing monitoring of resistance markers to guide effective malaria treatment strategies, especially in pregnant women and infants.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!